Drug-induced hepatitis in an acromegalic patient during combined treatment with pegvisomant and octreotide long-acting repeatable attributed to the use of pegvisomant

Research output: Contribution to journalArticleAcademicpeer-review

35 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)805-806
Number of pages2
JournalEuropean Journal of Endocrinology
Volume154
Issue number6
DOIs
Publication statusPublished - 2006

Research programs

  • EMC MM-01-39-01

Cite this